CAN Week 2 (breast Cancer) Flashcards
Triple approach for a breast lump
Clinical examination - palpating of breast to determine nature and feeling of abnormality
US +/- mammogram (sometimes MRI)
FNAC/B (sample lesion- cutting out cells into needle/ small tissue biopsy)
What clinical features would make you suspicious of a malignant lump
- irregular and hard
- fixed to the chest wall
- skin above is tethered
- palpable lymph nodes in axilla
- indrawn nipple / nipple involvement
- bone tenderness / pain
What is fibroadenoma
A benign breast tumour
Describe treatment of a breast lump
Surgery: wide local excision
Removal of lump with 2cm margin of normal breast tissue, preserving tissue
Sampling of axillary nodes same size
- specimens sent for histology for staging and grading
Different cancer treatments
Surgery
Radiotherapy
Chemotherapy
- neo-adjuvant
- adjuvant (chemo and surgery combined)
- palliative
Immunotherapy
What are antimetabolites
Interfere with metabolic pathways in DNA synthesis
- folate antagonist eg methotrexate, inhibits purine and pyrimidine synthesis
What are alkylating agents eg cyclophosphamide
Cause chemical, covalent cross-linking of DNA leading to defective DNA replication
- dna cant be unwinded for replication
What is the mode of action of platinum compounds eg cisplatin
Inhibition of DNA synthesis by cross linking guanine residues
What are false substrates eg 5-fluoruracil
Pyrimidine analogues
Inhibits thymidylate synthase
Incorporated into DNA as false metabolites and lead to damage of the DNA
What are anthracycline antibiotics eg doxorubicin
Interfere with nucleotide synthesis by intercalated between DNA strands, inhibiting topoisomerase and generating free radicals
What are topoisomerase inhibitors eg etoposide
Inhibition of topoisomerase II prevents ligation of DNA, leading to breaks in the DNA strand
What are microtubule inhibitors
Vinca alkaloids block the formation of the mitotic spindle
- taxanes stabilise spindle fibres
Side effects of anticancer drugs
- inhibit all fast growing cells (gut, epithelia, hair loss) myelosuppression (bone marrow) for all except vincristine
This causes ulcers in the mouth and diarrhoea
Myelosuppression:
- anaemia
- decreased resistance to infection (neutropenic sepsis)
- increasing bleeding
How can some of the side effects of anticancer drugs be overcome
Overcome reduced white counts with colony - stimulating factors
Prevents infections with antibiotics and antifungals
Other side effects of anti cancer drugs
Nausea: common esp with platinum compounds
- use of anti-emetics
Hair loss
Infertility (due to the drugs being highly damaging to rapidly dividing cells eg sperm)
Cardiotoxicity with anthracycline antibiotics
What is palliative care for cancer
Pain relief
Use strong opiods
- morphine and diamorphine
- oromorph for breakthrough pain
- constipation and nausea
- fentanyl patches
- syringe drivers
- hospice care
Symptoms of ovarian cancer
Abdominal pain Persistent indigestion / nausea Bloating Pain during sex Altered bowel habits Back pain Vaginal bleeding Tiredness Unintentional weight loss
How do targeted approach exploit biological weakness in tumours
Faulty genes
Faulty signalling systems
Tumour growth
Angiogenesis
What do hormonal targets do
May antagonise hormones responsible to promoting tumour growth eg oestrogen in breast cancer
Describe hormone based therapy in breast cancer
Oestrogen can stimulate the growth of metastasised cells (proliferation)
Tamoxifen is used as it blocks oestrogen as a selective oestrogen- receptor modulator (SERM) - reduces growth of oestrogen driven breast cancer. Used in ER+ breast cancer
- prevents bone loss via oestrogenic effects
Why is breast cancer more common in older generation
Over expression of oestrogen is more common in older population and oestrogen can drive proliferation of cancer cells
What are aromatase inhibitors eg anastrozole
An inhibitor that prevents peripheral conversion of androgens into oestrogen in post-menopausal women by the enzyme aromatase
How is oestrogen produced before and after menopause
Before: produced in ovaries
After: produced via the conversion of androgens via aromatase enzyme
What is HER2
Naturally present in low levels but can be over expressed in some cancers eg breast cancer
- more likely in older patients
- due to oncogene (ERBB2)
- affects gene transcription and cell cycle
What happens when HER2 becomes dysregulated
Over expression of some elements of DNA and dysregulation of cell cycle which leads to production of VEGF, COX2 and cyclins
What is trastuzumab
(MAB) large molecule approach
Selective to the HER2 receptor. (Targets it to slow down cell replication)
- manages early breast cancer and metastatic breast cancer with HER2 positive tumours
What is epidermal growth factor kinase eg erlotinib
- small molecule approach
- has utility in some lung and pancreatic cancer if they over express the EGF receptor
Mode of action of epidermal growth factor receptor
Phosphorylates tyrosine residues which alters DNA transcription and severs the cascade signalling at that point
(Targeting the activity of the second messenger)
Tyrosine kinase activity
Philadelphia chromosome associated with chronic myeloid leukaemia (more than 90% of patients with myeloid leukaemia produce an abnormal Ph chromosome)
- Ph chromosome produces bcr-abl protein which has tyrosine kinase activity
Tyrosine kinase inhibitor
Tyrosine kinase leads to uncontrolled cell proliferation
- imatinib inhibits TK acitivity
- selective inhibitor is very effective for chronic myeloid leukaemia
- trials >90% pts with CML alive after 5 years
What are PARP inhibitors eg olaparib
PARP: poly (ADP-ribose) polymerase
- an enzyme which repairs DNA
- BRCA genes important in DNA repair at double strange breaks: PARP enzyme repairs single strand breaks
- BRCA gene mutations: inhibition of PARP leads to inability of cancer cells to repair double strand breaks, leading to cell death
- can be used in chemoresistant ovarian cancer
Proteasome inhibitor
Proteasome: cellular structures which degrade proteins
- some proteins kill cancer cells: pro-apoptosic factors
- inhibition of intracellular proteasomes alters the regulation of intracellular proteins
Eg bortezomib used in multiple myeloma
What is anti- VEGF
Vascular endothelial growth factor
- VEGF secreted to promote angiogenesis (blood vessel growth to support metastasis)
What are the 2 anti- VEGF approaches
Bevacizumab: (MAB) - advanced colonic and breast cancer
Sunitinib: inhibits VEGF-associated receptor tyrosine kinase - advanced renal carcinoma
What is the cause of common genetic breast cancer
5-10% of breast cancer cases (BRCA)- due to highly penetrant germ line mutations in cancer predisposition genes
- up to half of these families will have mutations in BRCA1 or BRCA2
What are the different predisposition genes for inherited cancer
1) proto-oncogenes - genes whose action positively promotes cell proliferation
2) tumour suppressor genes- if not working you get uncontrolled cell growth
3) mutator genes : maintain the integrity of the genome
Syndromes caused by mutations in Porto-oncogenes
Multiple endocrine neoplasia type 2
MET- hereditary papillary renal carcinoma
Syndromes caused by mutations in tumour suppressor genes
PTEN: breast cancer, skin tumours, thyroid cancer
APC: familial, adenomatous, polposis coli
BRCA1/2: breast and ovarian cancer
TP53: young onset cancers particularly sarcoma and breast
What is Knudsons two hit hypothesis
Gene mutations may be inherited or acquired during a persons life
A cell can initiate a tumour only when it contains 2 mutant alleles
1st mutation: present in all the cells of the patient
2nd mutation: arises in a somatic cell in the organ in which the tumour develops (loss of heterozygosity) - tumour only develops after 2nd mutation